| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.32 | 4e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |